Form 3 filed by BVF PARTNERS L P/IL
BVF PARTNERS L P/IL filed this Form 3 on Foghorn Therapeutics Inc. with 0 transaction rows and 12 holding rows, accepted by EDGAR 2026-10-05 20:28:27 UTC.
- Accession
- 0000921895-26-002730
- Filer
- CIK 1055947
- Filed
- 2026-10-05
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: Foghorn Therapeutics Inc. (CIK 1822462)
- BVF PARTNERS L P/IL 10% owner
- BIOTECHNOLOGY VALUE FUND L P 10% owner
- BVF I GP LLC 10% owner
- BIOTECHNOLOGY VALUE FUND II LP 10% owner
- BVF II GP LLC 10% owner
- Biotechnology Value Trading Fund OS LP 10% owner
- BVF Partners OS Ltd. 10% owner
- BVF GP HOLDINGS LLC 10% owner
- BVF INC/IL 10% owner
- LAMPERT MARK N 10% owner
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share holding | 4,494,462 | D | ||||
| Common Stock, $0.0001 par value per share holding | 3,232,448 | D | ||||
| Common Stock, $0.0001 par value per share holding | 619,258 | D | ||||
| Pre-Funded Warrants to Purchase Common Stock derivativeholding | D | |||||
| Pre-Funded Warrants to Purchase Common Stock derivativeholding | D | |||||
| Pre-Funded Warrants to Purchase Common Stock derivativeholding | D | |||||
| Series 1 Warrants to Purchase Common Stock derivativeholding | D | |||||
| Series 1 Warrants to Purchase Common Stock derivativeholding | D | |||||
| Series 1 Warrants to Purchase Common Stock derivativeholding | D | |||||
| Series 2 Warrants to Purchase Common Stock derivativeholding | D | |||||
| Series 2 Warrants to Purchase Common Stock derivativeholding | D | |||||
| Series 2 Warrants to Purchase Common Stock derivativeholding | D |